Market Place
Sourcing Support
All News #Library
Sciences
Gilead takes an $820M hit after axing a Kite CAR-T
04 Feb 2019 //
ENDPTS
#ASH18: Gilead posts impressive survival rates for Yescarta
03 Dec 2018 //
ENDPTS
CAR-T Cell Therapy: Will First To Market Mean First To Disappoint?
06 Nov 2018 //
SEEKING ALPHA
With just $3M upfront, Sierra buys an unwanted Gilead late-stage cancer drug
22 Aug 2018 //
FIERCE BIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.